Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis
-
* Corresponding author: Philip F Stahel philip.stahel@dhha.org
Critical Care 2009, 13:R12 doi:10.1186/cc7710
Accesses
- Last 30 days: 34 accesses
- Last year: 569 accesses
- All time: 2702 accesses
Cited by
BioMed Central: 4 citations
|
Research
Michael A Flierl, Daniel Rittirsch, Sebastian Weckbach, Markus Huber-Lang, Kyros Ipaktchi, Peter A Ward, Philip F Stahel Annals of Intensive Care 2011, 1:53 (30 December 2011) |
|
Commentary
Septic-associated encephalopathy - everything starts at a microlevel Tarek Sharshar, Andrea Polito, Anthony Checinski, Robert D Stevens Critical Care 2010, 14:199 (29 September 2010) |
|
Commentary
Pathophysiology of septic encephalopathy - an unsolved puzzle Michael A Flierl, Daniel Rittirsch, Markus S Huber-Lang, Philip F Stahel Critical Care 2010, 14:165 (16 June 2010) |
|
Commentary
Sepsis-associated delirium: the pro and con of C5a blockade Djillali Annane Critical Care 2009, 13:135 (22 April 2009) |